Creative Medical Technology Holdings, Inc.CELZNASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -100.00% | +0.00% | +0.00% | -100.00% | +0.00% |
| Gross Profit Growth | -913.08% | +0.00% | +0.00% | -740.46% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | -2.73% | +18.86% | +39.35% | +83.64% | +85.35% |
| Weighted Average Shares Diluted Growth | -2.73% | +18.86% | +39.35% | +83.64% | +85.35% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | -56.45% | -66.73% | -84.93% | -70.71% | -70.71% |
| Asset Growth | -44.96% | -37.76% | -13.23% | -11.07% | -15.03% |
| Book Value per Share Growth | -44.25% | -48.42% | -37.32% | -51.17% | -53.99% |
| Debt Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| R&D Expense Growth | -41.39% | +35.04% | +75.97% | -45.79% | -20.05% |
| SG&A Expenses Growth | -6.11% | -0.40% | +32.30% | +8.20% | +55.80% |